Punt Blocking Peptide for STJ502734 peptide (STJ504839)
SPECIFICATIONS
ImmunogenSynthetic peptide corresponding to C terminal amino acids 497-515 of Drosophila melanogaster PUNT protein. Peptides were amidated for conjugation. Sequence: QLLIKNHTNIDDAKESTNCSynthetic peptide corresponding to C terminal amino acids 497-515 of Droso
General Information
| Short Description | Punt Blocking Peptide for STJ502734 is synthetically produced from the 497-515 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic peptide corresponding to C terminal amino acids 497-515 of Drosophila melanogaster PUNT protein. Peptides were amidated for conjugation. Sequence: QLLIKNHTNIDDAKESTNCSynthetic peptide corresponding to C terminal amino acids 497-515 of Droso |
| Immunogen Region | 497-515 |
| Specificity | This blocking peptide is recommended for use in combination with Punt antibody, STJ502734 |
Additional Info
| Background | ATP + [receptor-protein] = ADP + [receptor-protein] phosphate. |
Information sourced from Uniprot.org